AFT Pharmaceuticals Statistics

Total Valuation

AFT Pharmaceuticals has a market cap or net worth of NZD 335.57 million. The enterprise value is 355.72 million.

Market Cap	335.57M
Enterprise Value	355.72M

Important Dates

The next estimated earnings date is Thursday, November 21, 2024.

Earnings Date	Nov 21, 2024
Ex-Dividend Date	Jun 19, 2024

Share Statistics

AFT Pharmaceuticals has 104.87 million shares outstanding. The number of shares has increased by 0.02% in one year.

Shares Outstanding	104.87M
Shares Change (YoY)	+0.02%
Shares Change (QoQ)	+30.98%
Owned by Insiders (%)	69.34%
Owned by Institutions (%)	6.50%
Float	29.27M

Valuation Ratios

The trailing PE ratio is 21.50 and the forward PE ratio is 19.77. AFT Pharmaceuticals's PEG ratio is 0.69.

PE Ratio	21.50
Forward PE	19.77
PS Ratio	1.72
PB Ratio	3.82
P/FCF Ratio	11.67
PEG Ratio	0.69

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.99, with an EV/FCF ratio of 12.38.

EV / Earnings	22.79
EV / Sales	1.82
EV / EBITDA	13.99
EV / EBIT	14.68
EV / FCF	12.38

Financial Position

The company has a current ratio of 2.30, with a Debt / Equity ratio of 36.66.

Current Ratio	2.30
Quick Ratio	1.15
Debt / Equity	36.66
Debt / EBITDA	1.27
Debt / FCF	1.12
Interest Coverage	6.57

Financial Efficiency

Return on equity (ROE) is 19.38% and return on invested capital (ROIC) is 13.10%.

Return on Equity (ROE)	19.38%
Return on Assets (ROA)	9.67%
Return on Capital (ROIC)	13.10%
Revenue Per Employee	1.78M
Profits Per Employee	141,900
Employee Count	110
Asset Turnover	1.25
Inventory Turnover	2.34

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.07% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-5.07%
50-Day Moving Average	3.22
200-Day Moving Average	3.23
Relative Strength Index (RSI)	46.36
Average Volume (20 Days)	24,900

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AFT Pharmaceuticals had revenue of NZD 195.41 million and earned 15.61 million in profits. Earnings per share was 0.15.

Revenue	195.41M
Gross Profit	88.27M
Operating Income	24.24M
Pretax Income	22.02M
Net Income	15.61M
EBITDA	24.63M
EBIT	24.24M
Earnings Per Share (EPS)	0.15

Full Income Statement

Balance Sheet

The company has 12.04 million in cash and 32.19 million in debt, giving a net cash position of -20.15 million or -0.19 per share.

Cash & Cash Equivalents	12.04M
Total Debt	32.19M
Net Cash	-20.15M
Net Cash Per Share	-0.19
Equity (Book Value)	87.80M
Book Value Per Share	0.84
Working Capital	59.66M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 28.86 million and capital expenditures -116,000, giving a free cash flow of 28.75 million.

Operating Cash Flow	28.86M
Capital Expenditures	-116,000
Free Cash Flow	28.75M
FCF Per Share	0.27

Full Cash Flow Statement

Margins

Gross margin is 45.17%, with operating and profit margins of 12.40% and 7.99%.

Gross Margin	45.17%
Operating Margin	12.40%
Pretax Margin	11.27%
Profit Margin	7.99%
EBITDA Margin	12.61%
EBIT Margin	12.40%
FCF Margin	14.71%

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 0.50%.

Dividend Per Share	0.02
Dividend Yield	0.50%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	7.39%
Buyback Yield	-0.02%
Shareholder Yield	0.49%
Earnings Yield	4.65%
FCF Yield	8.57%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AFT Pharmaceuticals has an Altman Z-Score of 5.

Altman Z-Score	5
Piotroski F-Score	n/a